SM-7368

Research use only, not for human use.

The NF-κB Activation Inhibitor III, controls the biological activity of NF-κB. It is primarily used for Inflammation/Immunology applications.

The NF-κB Activation Inhibitor III, controls the biological activity of NF-κB. It is primarily used for Inflammation/Immunology applications.

SM-7368 (5 μM) targets downstream of MAPK p38 activation in the human colon derived crypt like HT-29 and Caco-2 epithelial cell lines.SM-7368 inhibits TNF-α-induced MMP-9 upregulation in a concentration-dependent manner and shows maximal activity at 10 μM. SM-7368 inhibits TNF-α-induced MMP-9 mRNA transcript accumulation and protein expression. SM-7368 strongly inhibits TNF-α-induced NF-κB activity but not AP-1 activity. SM-7368 strongly inhibits the TNF-α-induced invasion of HT1080 human fibrosarcoma cell line.SM-7368 (10-25 μM) greatly inhibits TNF-α (20 ng/mL)-induced MMP-9 upregulation. 10 μM of SM-7368 almost completely abrogates this upregulation. Western Blot AnalysisCell Line: HT1080 human fibrosarcoma cellsConcentration:0, 1, 5, 10, 15, 20, and 25 μMIncubation Time:24 hoursResult:Greatly inhibited TNF-α (20 ng/mL)-induced MMP-9 upregulation in a concentration-dependent manner.

——

NF-κB Activation Inhibitor III | SM 7368

Apoptosis

NF-κB

D4 receptor

——

——

380623-76-7

328.69

C10H5ClN4O5S

>98% (HPLC)

In Vitro:?DMSO : 83.33 mg/mL (253.52 mM)

[O-][N+](c1cnc(NC(c(cc2)cc(Cl)c2[N+]([O-])=O)=O)s1)=O

——

(-20℃)

With Ice Pack

≥ 2 years